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Abstract
Background: This paper reports the psychometric properties of the Chinese version of Craving Beliefs Questionnaire
(CCBQ), an easy-to-administer assessment instrument of measurement of craving beliefs for heroin abusers.
Methods: Participants were 445 heroin abusers from four methadone clinics in Northern Taiwan. Fifty-one of the
participants were tested twice within a two-week period at a different hospital to examine test-retest reliability.
Results: Three-factor solution using principal component analysis was identified in the CCBQ: will power,
compulsive behavior, and negative coping, accounting for 54.6% of the variance. Internal consistency analysis
indicated that the three factors have strong reliability, with Cronbach alphas ranging from .81 to .92. The test-retest
ICC coefficient is .80. The test-retest coefficients for the subscales will power, compulsive behavior, and negative
coping are .76, .51, and .64, respectively. Overall, the data show that the CCBQ has acceptable reliability and
validity, demonstrating that it can be a research instrument for assessing heroin craving beliefs.
Conclusions: The psychometric properties of the CCBQ seem promising for both research and clinical purposes,
and the scale thus deserves further refinement and validation with heroin abusers.
Background
Methadone treatment is used widely as the first-choice,
most available treatment for heroin dependence. Oral
ingestion of methadone cannot only help opiate addicts
prevent HIV infection, but it also reduces the negative
consequences of heroin abuse by managing withdrawal
syndromes and cravings [1,2]. Methadone maintenance
therapy primarily provides heroin-dependent patients
with long-term methadone and recovery plans, such as
hygiene training, routine physical and mental health
checkups, urine tests, and group psychological counsel-
ing [3,4]. Since the studies on the effects of methadone
on HIV prevention and heroin dependence syndrome,
public health researchers and psychiatrists have been
investigating how best to improve the outcomes and
outcome assessments further for their heroin dependent
participants. A study [5] found that patients with posi-
tive perceptions of methadone on craving management
showed better psychiatric functioning and stayed longer
in treatment.
Methadone is a complete opioid agonist used in psy-
chiatry for heroin detoxification [6], and so persons tak-
ing methadone should be able to delay their craving for
heroin. Hence, assessing changes in heroin craving and
craving beliefs during different periods of methadone
consumption can provide important information regard-
ing the efficacy of methadone treatment. A handful of
instruments have been designed to assess heroin craving
and craving beliefs in Western countries [7], and they
have been employed either singly or in combination in
pharmaceutical and/or psychosocial interventions for
addiction [8,9].
Craving is a construct that continues to be actively
debated in the substance dependence literature. Although
there is inconsistent evidence that it is linked to relapse,
craving is frequently reported as a trigger to relapse by
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any medium, provided the original work is properly cited.those trying to remain abstinent and is one of the diag-
nostic criteria for substance dependence. Craving is
viewed as a subjective experience and therefore is
assessed with self-report scales. The process of craving
involves physical, emotional,c o g n i t i v e ,a n db e h a v i o r a l
characteristics that have been well documented in the lit-
erature [10]. In addition, cravings can continue for
months and even years after the cessation of drug use
[11]. Rosenberg [7] provided a comprehensive review on
the self report assessment tools of the craving and con-
cluded that single-item ratings that focus on the inten-
sity, frequency or duration of craving may fail to assess
urges and craving if drug users attribute the feelings to
another psychological or physiological state. Hence,
single-item rating of subjec t i v ec r a v i n gm a yn o tw e l l
manifest the nature of craving. Moreover, assessing dif-
ferent dimensions of craving may predict different types
of outcome [12].
Evidence for the effectiveness of methadone programs
in reducing heroin use, reducing crime, improving
health, and limiting the spread of blood-borne viruses
such as HIV is substantial [13]. Strategies for improving
the effectiveness of existing medication programs are
now an area of growing interest. Although debate about
the components and diagnostic value of craving con-
tinues, reliable and valid measures of craving would
have advantages for clinical psychologists, physicians,
and researchers. However, few research attention has
been paid to the cravings or craving beliefs of Chinese
heroin dependent patients. Consequently, none of
assessment tool or criteria currently available addresses
the problem in Chinese culture. Hence, this paper
reports the psychometric properties of the Chinese
Craving Beliefs Questionnaire (CCBQ).
Methods
Participants and procedure
Data used in this article is from a larger longitudinal
study in Taiwan aiming to assess effectiveness of metha-
done treatment on quality of life, mortality, craving
beliefs, and HIV seroconversion. The study sample con-
sisted of 505 heroin abusing volunteers recruited from
four outpatient methadone treatment facilities located in
Northern Taiwan. During the recruitment, 94 metha-
done patients expressed unwillingness to participate in
this study. Potential participants were referred for the
study by the staff of methadone treatment facilities and
interviewed by trained interviewers between August and
November 2008. To be included in the sample, they had
to meet the DSM-IV-TR diagnostic criteria for heroin
abuse [14], be at least 18 years old, and currently
enrolled in a methadone program. All the participants
were reimbursed NT $100 (approximately 3USD) for
their participation.
In order to prevent contamination of the original
study sample, the test-retest reliability of the CCBQ,
additional sample of 51 methadone patients recruited
from another outpatient methadone treatment program
was enrolled and interviewed twice within a two-week
period.
Ethical approval
This study was approved by the Institutional Review
Board of Taipei Medical University (approval number:
P960205). All participants gave their written, informed
consent before they completed the questionnaire.
Measures
The CCBQ was adapted from a craving beliefs question-
naire (CBQ) developed by Wright [15], that measures
beliefs about and understanding of heroin cravings. The
initial version of the CCBQ consisted of 20 items trans-
lated from the English version of CBQ into Mandarin
with responses given on a 7-point Likert scale ranging
from totally disagree (1) to totally agree (7). The transla-
tor was fluent in both English and Mandarin, had a
Ph.D. in psychology, and experience of conducting
research in drug abuse for more than 10 years. The
initial Mandarin version of CCBQ was then back trans-
lated by a different translator (a Ph.D. in drug offense
and criminal justice). After the back-translation, the ori-
ginal and back-translated CCBQ were compared and all
points of divergence were corrected to more accurately
reflect the intent/accuracy of the item wording. The
final version of CCBQ was reviewed by a group of 7
researchers in fields of psychology, psychiatry, nurse and
biostatistics which determined the two language versions
to be closely equivalent.
The CCBQ was then pilot tested with 7 heroin abusers
in a prison to evaluate whether they can understand the
CCBQ items and if the questionnaire items are related to
their drug-using experience. Since the pilot test aimed to
make sure that heroin abusers can cognitively understand
the content and wording of items, choosing heroin abusers
in the jail can give us a nice, quite space to interact and
they were sober. In this initial pilot test, heroin users
revised some of item wording and responded that the
CCBQ format was difficult to read since they usually read
Mandarin from top to down and from right to left because
of traditional Mandarin classes taught in schools. They
also indicated having problems with using the 7-point
Likert scale and they suggested using a 5-point scale
labeled 0%, 25%, 50%, 75% and 100% of agreement with
the statement instead of the original 7-point scale. The
translated CCBQ had 20 items in Mandarin using 5-point
percentage scale oriented from top (0%) to bottom (100%)
which was then used in the field-testing to evaluate its
utility and selected psychometric properties.
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Five objectives were set for the development of this
instrument: (1) good content and face validity; (2) short
administration time; (3) simple scoring of clearly under-
standable items; (4) acceptable reliability; and (5) accep-
table construct and concurrent validity.
The Kaiser-Meyer-Olkin (KMO) statistic was used to
measure sampling adequacy and the Bartlett test of
sphericity was used to determining the necessity of a
factor analysis. The initial validity of the CCBQ was
assessed using a principal components analysis (PCA) of
a correlation matrix with Varimax rotation because we
are simply transforming the original items into the new
set of the principal components. The criteria for compo-
nent extraction were (1) an eigenvalue ≥ 1, (2) a satis-
factory result on Catell’s scree test[16], (3) four or more
items with salient loadings (i.e., ≥0.4), (4) reasonable
internal consistency for the unit-weighted salient items
(i.e., ≥0.7), and (5) adequate parsimony (mutually exclu-
sive assignment of items to factors).
The internal consistency and test-retest reliability of
the resulting components were determined by Cronbach
alpha and intra-class correlation (ICC) [17]. ICCs were
calculated as ratios of the variance components using a
fixed-effects analysis of variance. A general-case ICC for-
mula, described by Shrout & Fleiss [18], was adapted for
the present study. An ICC above .75 indicates excellent
test-retest reliability [19]. To compensate for the
increased likelihood of type-1 error caused by multiple
comparisons, the alpha level was adjusted so that p < .01
was required for statistical significance.
Results
Of the initial 505 methadone treatment users in the sam-
ple, 445 completed the CCBQ satisfactorily. Twenty-eight
did not complete all 20 items of CCBQ and 32 dropped of
this study after completing demographics and consent
forms. The demographics of 505 patients are presented in
Table 1. Their mean (SD) age was 40.7 ± 9.4 years, mean
age at first heroin use was 27.4 ± 7.5, and their mean (SD)
education grade level was 9.18 ± 2.22. Most were men
(87%); 84% had HCV; 13% were HIV positive. About 64%
were employed full-time at the time of interview and 36%
were unemployed. Average duration of enrolling in metha-
done was 184 days.
Component structure of the CCBQ
Table 2 presents the factor loadings of the principal
components analysis (PCA) and Cronbach alphas for
the 3-component model. The results of the PCA for the
445 participants revealed that one CCBQ item, “When
craving drugs it’s OK to use alcohol to cope” has low
loadings on the three factors; the loadings on factors
were all less than .40 and the item-total correlation is
low (r=.12) and was subsequently deleted from the
CCBQ scale.
The results indicated that the remaining 19 items fit a
3-component solution that meets the criteria listed in
Methods (eigenvalue ≥ 1; factor loading ≥ .40; Alpha
≥ .70). These three factors together explain 54.6% of the
total variance and yield excellent internal consistency coef-
ficients (≥0.8). The first and most influential component
consists of 10 items and explains 22.4% of the total
variance; this component was labeled “will power.” The
second component includes 5 items and explains 17.4% of
the total variance; this component was labeled “compul-
sive behavior.” The third component retains four items
and explains 14.8% of the total variance; this component
was labeled “negative coping.” The items comprising these
components are listed in Table 2. The sampling adequacy
of the model is good (KMO = 0.93) and the Bartlett test of
sphericity is significant (445, p < .01), indicating that the
model fit is good.
Reliability: Internal-consistency and test-retest
Of the 51 participants enrolled in test-retest phase of the
study, 46 filled out the CCBQ again after two weeks and
5 lost of contact. The results show that the test-retest
reliability using the ICC coefficient is .80. The test-retest
coefficients for the components “will power,”“ compulsive
behavior,” and “negative coping” are .76, .51, and .64,
respectively.
Possible CCBQ scores then range from 19 to 95 (M =
59.9, SD = 13.1). The CCBQ demonstrated acceptable
internal consistency, with Cronbach alpha for the total
Table 1 Demographic and clinical characteristics
according to the HIV serostatus of methadone patients
from four hospitals
Participants
N = 505
Age (years, mean ± SD) 40.7 ± 9.4
Age at first heroin use (years, mean ± SD) 27.4 ± 7.5
Education (years, mean ± SD) 9.18 ± 2.22
Average methadone dose at
interview
(mg, mean ± SD) 48.0 ± 32.8
Duration from intake to
interview
(days, mean ± SD) 184 ± 149
Gender Male 440 (87%)
Female 65 (13%)
Employed No 181 (36%)
Yes 324 (64%)
HCV Negative 79 (16%)
Positive 426 (84%)
HIV Negative 439(87%)
Positive 66 (13%)
Urine test at interview Negative 307 (61%)
Positive 198 (39%)
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range from .81 to .88 (Table 2).
Discussion
The final version of the CCBQ contains 19 items rated
on a 5-point percent agreement scale. The results of
principal components analysis of data collected from
heroin abusing individuals in Taiwan using the CCBQ
correspond closely with the results of previous research
representing heroin craving as related to three domains:
will power [20], compulsive behavior [21,22], and nega-
tive coping [23]. One item about using alcohol to cope
craving of heroin had to be deleted from the scale due
to low factor loading and low item-total correlation. We
speculate that is because when alcohol is a surrogate for
heroin, social adjustment improves, but the medical out-
come is worsened [24]. Overall, the results of our study
are also consistent with Tiffany’s proposition that crav-
ing is conceptually multi-dimensional [25].
A central objective in developing the CCBQ was to
create a short and easy to administer assessment instru-
ment with good psychometric properties. For most
participants, administration of the CCBQ took an aver-
age of 10 minutes. The items were also designed to be
easy to score and understand. The factor loadings, item
correlations, and Cronbach alpha values are similar to
those reported for other rating scales [26]. In sum, this
brief scale is composed of clear, simple items requiring
little judgment for scoring ,a n di tm e e t sg e n e r a l l y
accepted psychometric standards.
In conclusion, the results of the study indicate that the
reliability and validity of the CCBQ are promising and
that the scale deserves further refinement and more vali-
dation for use with drug abusers. The evidence also sup-
ports the conclusion that the collection of reliable data
by research or treatment personnel on the problems
experienced by heroin abusers for outcome evaluation
purposes need not be time-consuming. The results also
have several practical implications for outcome research.
If the CCBQ is to be used in routine clinical practice, it
may be advantageous to incorporate it within existing
assessment protocols. The short amount of time required
to administer the CCBQ is encouraging in this regard. In
short, the overall findings of the study support the
Table 2 The CCBQ items organized by factor
Item Component 1 Component 2 Component 3
Component 1: will power
16. I cannot do anything when I am really craving heroin. .76
12. The thoughts I have while craving heroin are out of my control. .70
20. Craving heroin defeats my will power. .70
9. I cannot stand the physical symptoms while craving heroin. .69
13. The craving makes me so nervous I can’t stand it. .65
18. Using heroin is the only way to cope with the feeling of craving. .63
17. Craving for heroin is all or none; there is nothing in between. .53
7. I have no control over my behavior once the craving starts. .52
10. Craving is my punishment for using heroin. .51
11. If you never used heroin then you have no idea what the craving is like. .49
Cronbach’s alpha = .88
Component 2: compulsive behavior
4. 4. Craving makes me use heroin. .76
3. Craving drives men mad. .73
2. If I don’t stop, the craving will be worse. .71
5. I will always have craving for heroin. .65
1. The craving is a physical reaction, hence I cannot resist it. .56
Cronbach’s alpha=.81
Component 3: negative coping
14. I will never be prepared to handle the craving. .78
8. I will crave heroin for the rest of my life. .74
15. Since I will have cravings for the rest of my life, I might as well go ahead and use heroin. .73
6. I don’t have any control over the craving. .53
Cronbach’s alpha=.81
Variance explained by each factor 22.4% 17.4% 14.8%
Cronbach’s alpha for CCBQ=.92
Overall variance explained by the 3-factor model: 54.6%
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further use for both research and clinical purposes.
Finally, a few limitations of the study should be men-
tioned. The participants were recruited from outpatient
methadone treatment clinics and our sample was not
randomly sampled. In addition, although the sample was
large, relatively diverse, and fairly typical of the demo-
graphic makeup of heroin abusers in Taiwan, the fact
remains that it was restricted to Chinese patients living
in Taiwan. Since the alcohol abuse was not assessed, the
lack of comorbidity assessment should be highlighted as
a limitation of the study. Therefore, caution should be
exercised in applying the proposed CCBQ structure to
other ethnic groups and in other countries. Nonetheless,
the sample used for the study and the attendant analyses
o ft h eC C B Qd a t as h o u l dp r o v i d eag o o dl a u n c h i n g
point for future tests of the construct, concurrent, and
convergent validity of the CCBQ and for treatment-out-
come research generally.
Conclusions
The primary findings in this article support that the
19-item CCBQ meets the criteria of a short and easy to
administer assessment instrument with great psycho-
metric properties. The findings of the CCBQ seem pro-
mising for both heroin craving related research and
clinical purposes.
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